Home › B-Cell Leukemia › Texas › Dallas
B-Cell Leukemia clinical trials in Dallas, TX
5 studies for B-Cell Leukemia are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RecruitingPhase 2
- UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecruitingPhase 2
- University of Texas, Southwestern, Dallas
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
RecruitingPhase 1
- UT Southwestern Medical Center, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingPhase 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
RecruitingObservational study
- Ut Southwestern, Dallas
B-Cell Leukemia trials in other cities
- Houston, TX7 studies
- Washington, DC5 studies
- Columbus, OH4 studies
- Portland, OR4 studies
- Philadelphia, PA3 studies
- Spokane, WA3 studies
- Boston, MA3 studies
- New York City, NY3 studies
- Clifton, NJ3 studies
- San Diego, CA3 studies
- Charlotte, NC3 studies
- Louisville, KY3 studies
Other studies in Dallas
- Breast Cancer55 studies
- Non-Small Cell Lung Cancer52 studies
- Metastatic Cancer42 studies
- Heart Failure42 studies
- Cancer (all types)37 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity30 studies
- Ovarian Cancer28 studies
- Bladder Cancer27 studies
- Lung Cancer27 studies
- Endometrial Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.